BPH Patients’ Response to Drug Therapy May Have a Genetic Determinant
News
Natural variations, called polymorphisms, in a nitric oxide coding gene may affect a benign prostatic hyperplasia (BPH) patient’s response to drug therapy for lower urinary tract symptoms (LUTS), according to a study, “The association ... Read more